UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetisch modifizierte regulatorische T-Zellen: Therapiekonzepte und ihr regulatorischer Rahmen

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2020, Vol.63 (11), p.1403-1411

2020

Volltextzugriff (PDF)

Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk Assessment

Cell stem cell, 2017-10, Vol.21 (4), p.427-430

2017

Volltextzugriff (PDF)

Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective

Advances in experimental medicine and biology, 2015-01, Vol.871, p.103

2015

Volltextzugriff (PDF)

Setting Goals with LEGO® SERIOUS PLAY: A Proven Approach for Forward-Thinking Organizations

2024th edition, 2024

Volltextzugriff (PDF)

Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer

PloS one, 2012-07, Vol.7 (7), p.e40611

2012

Volltextzugriff (PDF)

Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products

Biologicals, 2016-09, Vol.44 (5), p.467-479

2016

Volltextzugriff (PDF)

Cell therapy clinical trials in Germany – Critical aspects of quality data content: Summary of meeting presentation

Biologicals, 2015-09, Vol.43 (5), p.429-432

Renner, Matthias

2015

Volltextzugriff (PDF)

Cell therapy clinical trials in Germany – Critical aspects of quality data content

Biologicals, 2015-09, Vol.43 (5), p.429-432

Renner, Matthias

2015

Volltextzugriff (PDF)

Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma

Journal of neuro-oncology, 2011-03, Vol.102 (1), p.59-69

2011

Volltextzugriff (PDF)

Genetisch modifizierte Zellen zur Therapie verschiedener Erkrankungen

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2015-11, Vol.58 (11-12), p.1274-1280

2015

Volltextzugriff (PDF)

Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side

Critical reviews in biochemistry and molecular biology, 2017-07, Vol.52 (4), p.355-380

2017

Volltextzugriff (PDF)

Genetically modified regulatory T cells: therapeutic concepts and regulatory aspects

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2020-11, Vol.63 (11), p.1403-1411

2020

Volltextzugriff (PDF)

Suicide genes for cancer therapy

Molecular aspects of medicine, 2007-02, Vol.28 (1), p.4-41

2007

Volltextzugriff (PDF)

Effects of Viral Strain, Transgene Position, and Target Cell Type on Replication Kinetics, Genomic Stability, and Transgene Expression of Replication-Competent Murine Leukemia Virus-Based Vectors

Journal of Virology, 2007-07, Vol.81 (13), p.6973-6983

2007

Volltextzugriff (PDF)

Tissue- and Tumor-Specific Targeting of Murine Leukemia Virus-Based Replication-Competent Retroviral Vectors

Journal of Virology, 2006-07, Vol.80 (14), p.7070-7078

2006

Volltextzugriff (PDF)

Cytokine‐induced interleukin‐1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment

The journal of gene medicine, 2018-05, Vol.20 (5), p.e3021-n/a

2018

Volltextzugriff (PDF)

Verbriefung für Firmenkunden: Win-Win für Kunde und Bank

Schmalenbachs Zeitschrift für betriebswirtschaftliche Forschung, 2013, Vol.65 (Suppl 67), p.35-41

2013

Volltextzugriff (PDF)

Transgene Expression Facilitated by the v-src Splice Acceptor Can Impair Replication Kinetics and Lead to Genomic Instability of Rous Sarcoma Virus-Based Vectors

Journal of Virology, 2008-02, Vol.82 (3), p.1610-1614

2008

Volltextzugriff (PDF)

Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications

Cytotherapy (Oxford, England), 2015-02, Vol.17 (2), p.128-139

2015

Volltextzugriff (PDF)

A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV

Trends in molecular medicine, 2014-11, Vol.20 (11), p.632-642

2014

Volltextzugriff (PDF)

Therapeutic approaches using genetically modified cells

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2015-11, Vol.58 (11-12), p.1274-1280

2015

Volltextzugriff (PDF)

Multiple Modifications Allow High-Titer Production of Retroviral Vectors Carrying Heterologous Regulatory Elements

Journal of Virology, 2004-02, Vol.78 (3), p.1384-1392

2004

Volltextzugriff (PDF)

Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products

CRISPR journal, 2022-06, Vol.5 (3), p.364-376

2022

Volltextzugriff (PDF)

Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany

Advances in experimental medicine and biology, 2015, Vol.871, p.87

2015

Volltextzugriff (PDF)

Inflammation-induced transgene expression in genetically engineered equine mesenchymal stem cells

The journal of gene medicine, 2016-08, Vol.18 (8), p.154-164

2016

Volltextzugriff (PDF)

1 – 25 von 436

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(378)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Genetisch modifizierte regulatorische T-Zellen: Therapiekonzepte und ihr regulatorischer Rahmen

Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk Assessment

Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective

Setting Goals with LEGO® SERIOUS PLAY: A Proven Approach for Forward-Thinking Organizations

Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer

Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products

Cell therapy clinical trials in Germany – Critical aspects of quality data content: Summary of meeting presentation

Cell therapy clinical trials in Germany – Critical aspects of quality data content

Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma

Genetisch modifizierte Zellen zur Therapie verschiedener Erkrankungen

Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side

Genetically modified regulatory T cells: therapeutic concepts and regulatory aspects

Suicide genes for cancer therapy

Effects of Viral Strain, Transgene Position, and Target Cell Type on Replication Kinetics, Genomic Stability, and Transgene Expression of Replication-Competent Murine Leukemia Virus-Based Vectors

Tissue- and Tumor-Specific Targeting of Murine Leukemia Virus-Based Replication-Competent Retroviral Vectors

Cytokine‐induced interleukin‐1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment

Verbriefung für Firmenkunden: Win-Win für Kunde und Bank

Transgene Expression Facilitated by the v-src Splice Acceptor Can Impair Replication Kinetics and Lead to Genomic Instability of Rous Sarcoma Virus-Based Vectors

Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications

A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV

Therapeutic approaches using genetically modified cells

Multiple Modifications Allow High-Titer Production of Retroviral Vectors Carrying Heterologous Regulatory Elements

Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products

Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany

Inflammation-induced transgene expression in genetically engineered equine mesenchymal stem cells

Suchergebnisse filtern